Literature DB >> 27886681

Heterotopic Ossification in Trauma.

William R Barfield1, Robert E Holmes1, Langdon A Hartsock2.   

Abstract

Better understanding of the biology of heterotopic ossification (HO) formation will lead to treatment and prevention modalities that can be directed specifically at the cellular level. Early identification of HO precursor cells and target genes may provide prognostic value that guides individualized prophylactic treatment. Better understanding of molecular signaling and proteomics variability will allow surgeons to individualize preemptive treatment to suppress inflammation and formation of HO. Careful surgical technique to avoid muscle damage is important. Damaged muscle should be debrided as a prophylactic measure. Hemostasis and avoidance of a postoperative hematoma may decrease the chance of formation of HO. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemical prophylaxis; Classification; Heterotopic ossification; Pathophysiology; Radiation; Surgical debridement; Surgical excision

Mesh:

Year:  2016        PMID: 27886681     DOI: 10.1016/j.ocl.2016.08.009

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  10 in total

1.  Breath of relief: apparent pulmonary nodule due to heterotopic ossification.

Authors:  Eric Abston; Robert Novaco; Stephanie Hon; Jonathan Scalera; Katrina Steiling
Journal:  Clin Case Rep       Date:  2018-04-06

2.  A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation.

Authors:  Jung-Min Kim; Yeon-Suk Yang; Kwang Hwan Park; Xianpeng Ge; Ren Xu; Na Li; Minkyung Song; Hyunho Chun; Seoyeon Bok; Julia F Charles; Odile Filhol-Cochet; Brigitte Boldyreff; Teresa Dinter; Paul B Yu; Ning Kon; Wei Gu; Takeshi Takarada; Matthew B Greenblatt; Jae-Hyuck Shim
Journal:  Nat Commun       Date:  2020-05-08       Impact factor: 14.919

3.  Chronic dysphagia caused by Laryngo-vertebral Synostosis after anterior fusion for cervical spine trauma: a case report.

Authors:  Ichiro Okano; Joe Omata; Yushi Hoshino; Yuki Usui; Tomoaki Toyone; Katsunori Inagaki
Journal:  BMC Musculoskelet Disord       Date:  2020-03-04       Impact factor: 2.362

4.  Development of a rodent high-energy blast injury model for investigating conditions associated with traumatic amputations.

Authors:  Zepur Kazezian; Xiancheng Yu; Martin Ramette; Warren Macdonald; Anthony M J Bull
Journal:  Bone Joint Res       Date:  2021-03       Impact factor: 5.853

Review 5.  Neurological heterotopic ossification: novel mechanisms, prognostic biomarkers and prophylactic therapies.

Authors:  Ker Rui Wong; Richelle Mychasiuk; Terence J O'Brien; Sandy R Shultz; Stuart J McDonald; Rhys D Brady
Journal:  Bone Res       Date:  2020-12-09       Impact factor: 13.567

6.  Rapidly developed heterotopic ossification: a rare complication after trauma.

Authors:  Jae H T Lee; Janaka Balasooriya; Thembekile Ncube
Journal:  J Surg Case Rep       Date:  2022-04-18

Review 7.  Treatments and Preventative Measures for Trauma-Induced Heterotopic Ossification: A Review.

Authors:  Jessica K Juarez; Joseph C Wenke; Jessica C Rivera
Journal:  Clin Transl Sci       Date:  2018-04-26       Impact factor: 4.689

Review 8.  The Survey of Cells Responsible for Heterotopic Ossification Development in Skeletal Muscles-Human and Mouse Models.

Authors:  Łukasz Pulik; Bartosz Mierzejewski; Maria A Ciemerych; Edyta Brzóska; Paweł Łęgosz
Journal:  Cells       Date:  2020-05-26       Impact factor: 6.600

Review 9.  Heterotopic ossification of tendon and ligament.

Authors:  Qiang Zhang; Dong Zhou; Haitao Wang; Jun Tan
Journal:  J Cell Mol Med       Date:  2020-04-15       Impact factor: 5.310

10.  Inhibition of IL-17 prevents the progression of traumatic heterotopic ossification.

Authors:  Bing Tu; Bo Yu; Wei Wang; Juehong Li; Feng Yuan; Jing Zhu; Cunyi Fan
Journal:  J Cell Mol Med       Date:  2021-06-29       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.